Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelly Hendricks

Adult Reconstructive Orthopaedic Surgery Overland Park, KS Medical Doctor

NPI 1043329147 CMS profile 2758

5701 W 119Th St Ste 410, Overland Park, KS 66209

Open in the dashboard

General payments

$250,182

314 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kelly Hendricks of Overland Park, KS is reported in the CMS Open Payments database as having received $250,182 across 314 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,318 18
2024 General $10,028 25
2023 General $41,032 40
2022 General $34,167 43
2021 General $81,340 92
2020 General $47,773 48
2019 General $22,522 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelly Hendricks
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kelly Hendricks were reported at $13,318. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Kelly Hendricks Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $22,522 $1,416 $292–$9,336 $163
2020 $47,773 $647 $141–$6,474 $114
2021 $81,340 $1,073 $211–$6,497 $132
2022 $34,167 $1,217 $236–$6,299 $149
2023 $41,032 $1,082 $246–$6,818 $160
2024 $10,028 $1,575 $323–$8,944 $164
2025 $13,318 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $231,382 294 payments
  2. Medical Device Business Services, Inc. $16,669 15 payments
  3. DePuy Synthes Products, Inc. $1,755 1 payment
  4. Orthalign Inc $148 1 payment
  5. Medacta USA, Inc. $109 1 payment
  6. DePuy Synthes Sales Inc. $106 1 payment
  7. Currax Pharmaceuticals LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $198,817 93 payments
  2. Travel and Lodging $26,928 131 payments
  3. Education $19,560 15 payments
  4. Food and Beverage $4,877 75 payments
Products named General payments · program years 2019–2025
  1. ROSA $53,311 57 payments
  2. Persona Revision Knees $50,570 43 payments
  3. Persona Revision Knees $30,733 49 payments
  4. Persona Knees $25,157 42 payments
  5. Persona Knees $21,060 15 payments
  6. ATTUNE $18,279 15 payments
  7. LPS $13,884 3 payments
  8. ROSA-Knee $11,334 15 payments
  9. S-ROM NOILES $9,360 1 payment
  10. NexGen $8,273 3 payments
  11. Other $37,329 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

253

Median for Orthopedic Surgery: 203

Drug cost

$716

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 176 $531
Clindamycin Hcl Generic 53 $122
Meloxicam Generic 24 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$210,736

Of which drugs: $1,053

Medicare patients

418

Average age 73

Services billed

2,325

259 women, 159 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 28%
Depression 25%
Diabetes 24%
Chronic kidney disease 21%
Osteoporosis 17%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 17 1,240 $125

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

314 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record